| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | adenylate cyclase activity | 2.51e-06 | 18 | 110 | 4 | GO:0004016 | |
| GeneOntologyMolecularFunction | cyclase activity | 8.51e-06 | 24 | 110 | 4 | GO:0009975 | |
| GeneOntologyMolecularFunction | phosphorus-oxygen lyase activity | 1.01e-05 | 25 | 110 | 4 | GO:0016849 | |
| GeneOntologyMolecularFunction | lyase activity | 1.74e-04 | 212 | 110 | 7 | GO:0016829 | |
| GeneOntologyMolecularFunction | protein serine kinase activity | 1.82e-04 | 363 | 110 | 9 | GO:0106310 | |
| GeneOntologyMolecularFunction | transition metal ion binding | ADCY10 TES ESRRA ESRRG PEX12 F5 ADCY2 PPM1A PHC1 PHC2 APIP ZFAND1 PHC3 EHMT1 UTRN ZMAT1 PCK2 | 2.66e-04 | 1189 | 110 | 17 | GO:0046914 |
| GeneOntologyMolecularFunction | calcium- and calmodulin-responsive adenylate cyclase activity | 2.97e-04 | 5 | 110 | 2 | GO:0008294 | |
| GeneOntologyMolecularFunction | phosphotransferase activity, alcohol group as acceptor | CDC42BPA ERN1 TRIO KALRN CDKL4 DGKE TTK MAP3K5 FAM20B NT5C2 EIF2AK4 MAP3K15 | 5.35e-04 | 709 | 110 | 12 | GO:0016773 |
| GeneOntologyMolecularFunction | manganese ion binding | 6.38e-04 | 71 | 110 | 4 | GO:0030145 | |
| GeneOntologyMolecularFunction | transferase activity, transferring phosphorus-containing groups | PCYT1A CDC42BPA ERN1 TRIO KALRN CDKL4 DGKE TTK MAP3K5 FAM20B NT5C2 EIF2AK4 MAP3K15 ART5 | 6.39e-04 | 938 | 110 | 14 | GO:0016772 |
| GeneOntologyMolecularFunction | protein serine/threonine kinase activity | 8.10e-04 | 446 | 110 | 9 | GO:0004674 | |
| GeneOntologyMolecularFunction | kinase activity | CDC42BPA ERN1 TRIO KALRN CDKL4 DGKE TTK MAP3K5 FAM20B NT5C2 EIF2AK4 MAP3K15 | 1.03e-03 | 764 | 110 | 12 | GO:0016301 |
| GeneOntologyMolecularFunction | complement component C1q complex binding | 1.31e-03 | 10 | 110 | 2 | GO:0001849 | |
| GeneOntologyMolecularFunction | estrogen response element binding | 1.60e-03 | 11 | 110 | 2 | GO:0034056 | |
| GeneOntologyMolecularFunction | benzodiazepine receptor activity | 1.60e-03 | 11 | 110 | 2 | GO:0008503 | |
| GeneOntologyBiologicalProcess | vesicle cargo loading | 3.25e-08 | 36 | 109 | 6 | GO:0035459 | |
| GeneOntologyBiologicalProcess | cAMP biosynthetic process | 2.37e-07 | 11 | 109 | 4 | GO:0006171 | |
| GeneOntologyBiologicalProcess | cyclic nucleotide biosynthetic process | 6.05e-06 | 23 | 109 | 4 | GO:0009190 | |
| GeneOntologyBiologicalProcess | cAMP metabolic process | 8.57e-06 | 25 | 109 | 4 | GO:0046058 | |
| GeneOntologyBiologicalProcess | cyclic purine nucleotide metabolic process | 8.51e-05 | 44 | 109 | 4 | GO:0052652 | |
| GeneOntologyBiologicalProcess | cyclic nucleotide metabolic process | 9.30e-05 | 45 | 109 | 4 | GO:0009187 | |
| GeneOntologyBiologicalProcess | cellular response to forskolin | 1.11e-04 | 18 | 109 | 3 | GO:1904322 | |
| GeneOntologyBiologicalProcess | response to forskolin | 1.31e-04 | 19 | 109 | 3 | GO:1904321 | |
| GeneOntologyCellularComponent | endoplasmic reticulum exit site | 2.68e-06 | 42 | 110 | 5 | GO:0070971 | |
| GeneOntologyCellularComponent | PRC1 complex | 1.29e-04 | 19 | 110 | 3 | GO:0035102 | |
| GeneOntologyCellularComponent | IRE1-TRAF2-ASK1 complex | 1.64e-04 | 4 | 110 | 2 | GO:1990604 | |
| MousePheno | abnormal sternum morphology | DGKE ANKRD18B PHC1 MKS1 PHC2 PHF20L1 AASS GLI3 ARID5B ANKRD18A | 3.99e-06 | 255 | 87 | 10 | MP:0000157 |
| MousePheno | abnormal pectoral girdle bone morphology | DGKE ANKRD18B PHC1 MKS1 PHC2 PHF20L1 AASS GLI3 ARID5B ANKRD18A | 1.71e-05 | 301 | 87 | 10 | MP:0004508 |
| Domain | Znf_FCS | 1.71e-06 | 5 | 105 | 3 | IPR012313 | |
| Domain | Nucleotide_cyclase | 2.72e-06 | 18 | 105 | 4 | IPR029787 | |
| Domain | - | 2.72e-06 | 18 | 105 | 4 | 3.30.70.1230 | |
| Domain | ZF_FCS | 3.41e-06 | 6 | 105 | 3 | PS51024 | |
| Domain | GUANYLATE_CYCLASE_1 | 3.43e-06 | 19 | 105 | 4 | PS00452 | |
| Domain | Guanylate_cyc | 3.43e-06 | 19 | 105 | 4 | PF00211 | |
| Domain | GUANYLATE_CYCLASE_2 | 3.43e-06 | 19 | 105 | 4 | PS50125 | |
| Domain | A/G_cyclase | 3.43e-06 | 19 | 105 | 4 | IPR001054 | |
| Domain | CYCc | 3.43e-06 | 19 | 105 | 4 | SM00044 | |
| Domain | AC_N | 9.47e-06 | 8 | 105 | 3 | IPR032628 | |
| Domain | Adcy | 9.47e-06 | 8 | 105 | 3 | IPR030672 | |
| Domain | AC_N | 9.47e-06 | 8 | 105 | 3 | PF16214 | |
| Domain | Spectrin_repeat | 2.01e-05 | 29 | 105 | 4 | IPR002017 | |
| Domain | Spectrin/alpha-actinin | 3.00e-05 | 32 | 105 | 4 | IPR018159 | |
| Domain | SPEC | 3.00e-05 | 32 | 105 | 4 | SM00150 | |
| Domain | Oest-rel_rcp | 9.36e-05 | 3 | 105 | 2 | IPR027289 | |
| Domain | DUF4071 | 9.36e-05 | 3 | 105 | 2 | IPR025136 | |
| Domain | DUF4071 | 9.36e-05 | 3 | 105 | 2 | PF13281 | |
| Domain | A/G_cyclase_CS | 1.11e-04 | 17 | 105 | 3 | IPR018297 | |
| Domain | Ser/Thr_kinase_AS | 1.85e-04 | 357 | 105 | 9 | IPR008271 | |
| Domain | S_TKc | 1.92e-04 | 359 | 105 | 9 | SM00220 | |
| Domain | PROTEIN_KINASE_ST | 2.05e-04 | 362 | 105 | 9 | PS00108 | |
| Domain | Spectrin | 2.82e-04 | 23 | 105 | 3 | PF00435 | |
| Domain | Pkinase | 2.99e-04 | 381 | 105 | 9 | PF00069 | |
| Domain | Anaphylatoxin_comp_syst | 3.10e-04 | 5 | 105 | 2 | IPR018081 | |
| Domain | Anaphylatoxn_comp_syst_dom | 3.10e-04 | 5 | 105 | 2 | IPR001840 | |
| Domain | Oest_rcpt/oest-rel_rcp | 3.10e-04 | 5 | 105 | 2 | IPR024178 | |
| Domain | Adcy_conserved_dom | 4.63e-04 | 6 | 105 | 2 | IPR009398 | |
| Domain | GABAAa_rcpt | 4.63e-04 | 6 | 105 | 2 | IPR001390 | |
| Domain | DUF1053 | 4.63e-04 | 6 | 105 | 2 | PF06327 | |
| Domain | - | 5.04e-04 | 248 | 105 | 7 | 1.25.40.20 | |
| Domain | SAM/pointed | 5.19e-04 | 117 | 105 | 5 | IPR013761 | |
| Domain | ANK_REPEAT | 5.68e-04 | 253 | 105 | 7 | PS50088 | |
| Domain | Ankyrin_rpt-contain_dom | 5.81e-04 | 254 | 105 | 7 | IPR020683 | |
| Domain | ANK_REP_REGION | 5.81e-04 | 254 | 105 | 7 | PS50297 | |
| Domain | RhoGEF | 5.83e-04 | 68 | 105 | 4 | SM00325 | |
| Domain | ANATO | 6.45e-04 | 7 | 105 | 2 | SM00104 | |
| Domain | ANATO | 6.45e-04 | 7 | 105 | 2 | PF01821 | |
| Domain | ANAPHYLATOXIN_2 | 6.45e-04 | 7 | 105 | 2 | PS01178 | |
| Domain | ANAPHYLATOXIN_1 | 6.45e-04 | 7 | 105 | 2 | PS01177 | |
| Domain | Anaphylatoxin/fibulin | 6.45e-04 | 7 | 105 | 2 | IPR000020 | |
| Domain | RhoGEF | 6.50e-04 | 70 | 105 | 4 | PF00621 | |
| Domain | DH_2 | 6.50e-04 | 70 | 105 | 4 | PS50010 | |
| Domain | DH-domain | 6.86e-04 | 71 | 105 | 4 | IPR000219 | |
| Domain | - | 6.86e-04 | 71 | 105 | 4 | 1.20.900.10 | |
| Domain | Ankyrin_rpt | 6.98e-04 | 262 | 105 | 7 | IPR002110 | |
| Domain | Thiol-ester_cl | 8.57e-04 | 8 | 105 | 2 | PF10569 | |
| Domain | MacrogloblnA2_thiol-ester-bond | 8.57e-04 | 8 | 105 | 2 | IPR019565 | |
| Domain | MacrogloblnA2_CS | 8.57e-04 | 8 | 105 | 2 | IPR019742 | |
| Domain | PROTEIN_KINASE_ATP | 1.13e-03 | 459 | 105 | 9 | PS00107 | |
| Domain | Retinoid-X_rcpt/HNF4 | 1.37e-03 | 10 | 105 | 2 | IPR000003 | |
| Domain | A2M_N | 1.37e-03 | 10 | 105 | 2 | PF01835 | |
| Domain | A2M_N | 1.37e-03 | 10 | 105 | 2 | IPR002890 | |
| Domain | A-macroglobulin_rcpt-bd | 1.37e-03 | 10 | 105 | 2 | IPR009048 | |
| Domain | ALPHA_2_MACROGLOBULIN | 1.37e-03 | 10 | 105 | 2 | PS00477 | |
| Domain | A2M | 1.37e-03 | 10 | 105 | 2 | PF00207 | |
| Domain | A2M_N_2 | 1.37e-03 | 10 | 105 | 2 | IPR011625 | |
| Domain | A2M_comp | 1.37e-03 | 10 | 105 | 2 | IPR011626 | |
| Domain | A2M_N_2 | 1.37e-03 | 10 | 105 | 2 | PF07703 | |
| Domain | A2M_recep | 1.37e-03 | 10 | 105 | 2 | PF07677 | |
| Domain | A2M_comp | 1.37e-03 | 10 | 105 | 2 | PF07678 | |
| Domain | Macroglobln_a2 | 1.37e-03 | 10 | 105 | 2 | IPR001599 | |
| Domain | Prot_kinase_dom | 1.75e-03 | 489 | 105 | 9 | IPR000719 | |
| Domain | Ank | 1.83e-03 | 228 | 105 | 6 | PF00023 | |
| Domain | PROTEIN_KINASE_DOM | 1.85e-03 | 493 | 105 | 9 | PS50011 | |
| Domain | ABC_tran | 2.49e-03 | 48 | 105 | 3 | PF00005 | |
| Domain | ABC_TRANSPORTER_2 | 2.49e-03 | 48 | 105 | 3 | PS50893 | |
| Domain | ABC_TRANSPORTER_1 | 2.64e-03 | 49 | 105 | 3 | PS00211 | |
| Domain | ABC_transporter-like | 2.79e-03 | 50 | 105 | 3 | IPR003439 | |
| Domain | ANK | 2.95e-03 | 251 | 105 | 6 | SM00248 | |
| Domain | Kinase-like_dom | 3.48e-03 | 542 | 105 | 9 | IPR011009 | |
| Domain | C345C | 4.03e-03 | 17 | 105 | 2 | SM00643 | |
| Domain | C1_1 | 4.05e-03 | 57 | 105 | 3 | PF00130 | |
| Domain | Terpenoid_cyclase/PrenylTrfase | 4.52e-03 | 18 | 105 | 2 | IPR008930 | |
| Domain | NTR | 5.03e-03 | 19 | 105 | 2 | PF01759 | |
| Domain | Netrin_module_non-TIMP | 5.03e-03 | 19 | 105 | 2 | IPR018933 | |
| Domain | DH_1 | 5.37e-03 | 63 | 105 | 3 | PS00741 | |
| Domain | ZF_DAG_PE_1 | 5.61e-03 | 64 | 105 | 3 | PS00479 | |
| Domain | ZF_DAG_PE_2 | 5.61e-03 | 64 | 105 | 3 | PS50081 | |
| Pathway | WP_MAJOR_RECEPTORS_TARGETED_BY_EPINEPHRINE_AND_NOREPINEPHRINE | 1.58e-06 | 16 | 79 | 4 | M39849 | |
| Pathway | REACTOME_SIGNALING_BY_HEDGEHOG | 1.14e-05 | 137 | 79 | 7 | MM15182 | |
| Pathway | REACTOME_ADENYLATE_CYCLASE_ACTIVATING_PATHWAY | 1.98e-05 | 10 | 79 | 3 | M19522 | |
| Pathway | REACTOME_ADENYLATE_CYCLASE_ACTIVATING_PATHWAY | 1.98e-05 | 10 | 79 | 3 | MM14668 | |
| Pathway | REACTOME_SIGNALING_BY_HEDGEHOG | 2.05e-05 | 150 | 79 | 7 | M27440 | |
| Pathway | REACTOME_GABA_RECEPTOR_ACTIVATION | 2.09e-05 | 60 | 79 | 5 | MM15708 | |
| Pathway | REACTOME_GABA_RECEPTOR_ACTIVATION | 2.09e-05 | 60 | 79 | 5 | M976 | |
| Pathway | REACTOME_HEDGEHOG_OFF_STATE | 2.65e-05 | 105 | 79 | 6 | MM15206 | |
| Pathway | REACTOME_HEDGEHOG_OFF_STATE | 4.01e-05 | 113 | 79 | 6 | M27471 | |
| Pathway | REACTOME_ADENYLATE_CYCLASE_INHIBITORY_PATHWAY | 5.90e-05 | 14 | 79 | 3 | MM14669 | |
| Pathway | REACTOME_ADENYLATE_CYCLASE_INHIBITORY_PATHWAY | 5.90e-05 | 14 | 79 | 3 | M750 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EP_NE_ADRB_CAMP_SIGNALING_PATHWAY | 7.34e-05 | 15 | 79 | 3 | M47794 | |
| Pathway | PID_LPA4_PATHWAY | 7.34e-05 | 15 | 79 | 3 | M56 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PTH_PTH1R_PKA_SIGNALING_PATHWAY | 7.34e-05 | 15 | 79 | 3 | M47504 | |
| Pathway | KEGG_MEDICUS_REFERENCE_LHCGR_GNAS_PKA_SIGNALING_PATHWAY | 9.00e-05 | 16 | 79 | 3 | M47645 | |
| Pathway | KEGG_MEDICUS_REFERENCE_FSHR_GNAS_PKA_SIGNALING_PATHWAY | 9.00e-05 | 16 | 79 | 3 | M47650 | |
| Pathway | REACTOME_PKA_MEDIATED_PHOSPHORYLATION_OF_CREB | 9.00e-05 | 16 | 79 | 3 | MM14492 | |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_METHYLATION_PROTEINS | 9.00e-05 | 16 | 79 | 3 | M27403 | |
| Pathway | REACTOME_PKA_ACTIVATION_IN_GLUCAGON_SIGNALLING | 1.09e-04 | 17 | 79 | 3 | M26995 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CX3CR1_GNAI_AC_PKA_SIGNALING_PATHWAY | 1.09e-04 | 17 | 79 | 3 | M47544 | |
| Pathway | WP_ENVELOPE_PROTEINS_AND_THEIR_POTENTIAL_ROLES_IN_EDMD_PHYSIOPATHOLOGY | 1.25e-04 | 46 | 79 | 4 | M39828 | |
| Pathway | REACTOME_PKA_MEDIATED_PHOSPHORYLATION_OF_CREB | 1.80e-04 | 20 | 79 | 3 | M759 | |
| Pathway | REACTOME_NRAGE_SIGNALS_DEATH_THROUGH_JNK | 2.02e-04 | 52 | 79 | 4 | MM14743 | |
| Pathway | WP_PHOSPHODIESTERASES_IN_NEURONAL_FUNCTION | 2.51e-04 | 55 | 79 | 4 | M39763 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_GNAS_TO_CRHR_PKA_ACTH_SIGNALING_PATHWAY | 3.15e-04 | 24 | 79 | 3 | M47520 | |
| Pathway | REACTOME_NRAGE_SIGNALS_DEATH_THROUGH_JNK | 3.29e-04 | 59 | 79 | 4 | M11215 | |
| Pathway | WP_THERMOGENESIS | 3.45e-04 | 108 | 79 | 5 | M39746 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_E2F6 | 3.56e-04 | 25 | 79 | 3 | MM15546 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HCMV_UL33_TO_GNAI_AC_PKA_SIGNALING_PATHWAY | 4.01e-04 | 26 | 79 | 3 | M47553 | |
| Pathway | REACTOME_CA_DEPENDENT_EVENTS | 4.01e-04 | 26 | 79 | 3 | MM14495 | |
| Pathway | KEGG_MEDICUS_REFERENCE_DEUBIQUITINATION_OF_H2AK119 | 4.01e-04 | 26 | 79 | 3 | M47923 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CRHR_PKA_ACTH_SIGNALING_PATHWAY | 4.50e-04 | 27 | 79 | 3 | M47518 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_RASD1_TO_CRHR_PKA_ACTH_SIGNALING_PATHWAY | 4.50e-04 | 27 | 79 | 3 | M47519 | |
| Pathway | KEGG_MEDICUS_REFERENCE_GHRHR_PKA_GH_SIGNALING_PATHWAY | 5.02e-04 | 28 | 79 | 3 | M47647 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TSH_TG_SIGNALING_PATHWAY | 5.57e-04 | 29 | 79 | 3 | M47627 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_GNAS_TO_ACTH_CORTISOL_SIGNALING_PATHWAY | 5.57e-04 | 29 | 79 | 3 | M47515 | |
| Pathway | REACTOME_CELL_DEATH_SIGNALLING_VIA_NRAGE_NRIF_AND_NADE | 6.33e-04 | 70 | 79 | 4 | MM14824 | |
| Pathway | REACTOME_ACTIVATION_OF_C3_AND_C5 | 6.39e-04 | 7 | 79 | 2 | MM14685 | |
| Pathway | KEGG_MEDICUS_REFERENCE_IRE1A_JNK_SIGNALING_PATHWAY | 6.39e-04 | 7 | 79 | 2 | M47697 | |
| Pathway | KEGG_MEDICUS_VARIANT_CYP11B1_CYP11B2_FUSION_TO_ACTH_CORTISOL_SIGNALING_PATHWAY | 6.80e-04 | 31 | 79 | 3 | M47507 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ACTH_CORTISOL_SIGNALING_PATHWAY | 7.47e-04 | 32 | 79 | 3 | M47506 | |
| Pathway | REACTOME_G_ALPHA_Z_SIGNALLING_EVENTS | 8.19e-04 | 33 | 79 | 3 | MM15058 | |
| Pathway | REACTOME_GLUCAGON_SIGNALING_IN_METABOLIC_REGULATION | 8.19e-04 | 33 | 79 | 3 | M11575 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CLASSICAL_PATHWAY_OF_COMPLEMENT_CASCADE_C4_C2_TO_C3_CONVERTASE_FORMATION | 8.49e-04 | 8 | 79 | 2 | M47872 | |
| Pathway | REACTOME_ACTIVATION_OF_C3_AND_C5 | 8.49e-04 | 8 | 79 | 2 | M27031 | |
| Pathway | REACTOME_CELL_DEATH_SIGNALLING_VIA_NRAGE_NRIF_AND_NADE | 8.63e-04 | 76 | 79 | 4 | M19832 | |
| Pathway | REACTOME_RUNX1_INTERACTS_WITH_CO_FACTORS_WHOSE_PRECISE_EFFECT_ON_RUNX1_TARGETS_IS_NOT_KNOWN | 8.94e-04 | 34 | 79 | 3 | MM15531 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_E2F6 | 8.94e-04 | 34 | 79 | 3 | M27826 | |
| Pathway | REACTOME_G_ALPHA_12_13_SIGNALLING_EVENTS | 9.07e-04 | 77 | 79 | 4 | MM15044 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ADRB3_UCP1_SIGNALING_PATHWAY | 9.74e-04 | 35 | 79 | 3 | M47969 | |
| Pathway | REACTOME_G_ALPHA_12_13_SIGNALLING_EVENTS | 1.05e-03 | 80 | 79 | 4 | M800 | |
| Pathway | REACTOME_CARGO_CONCENTRATION_IN_THE_ER | 1.06e-03 | 36 | 79 | 3 | MM15300 | |
| Pathway | BIOCARTA_FLUMAZENIL_PATHWAY | 1.09e-03 | 9 | 79 | 2 | M22034 | |
| Pathway | REACTOME_DCC_MEDIATED_ATTRACTIVE_SIGNALING | 1.09e-03 | 9 | 79 | 2 | MM15059 | |
| Pathway | REACTOME_RUNX1_INTERACTS_WITH_CO_FACTORS_WHOSE_PRECISE_EFFECT_ON_RUNX1_TARGETS_IS_NOT_KNOWN | 1.15e-03 | 37 | 79 | 3 | M27797 | |
| Pathway | REACTOME_CA_DEPENDENT_EVENTS | 1.15e-03 | 37 | 79 | 3 | M749 | |
| Pathway | PID_RAC1_REG_PATHWAY | 1.24e-03 | 38 | 79 | 3 | M241 | |
| Pathway | REACTOME_NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION | 1.27e-03 | 144 | 79 | 5 | MM14501 | |
| Pathway | REACTOME_P75_NTR_RECEPTOR_MEDIATED_SIGNALLING | 1.31e-03 | 85 | 79 | 4 | MM14746 | |
| Pathway | REACTOME_G_PROTEIN_MEDIATED_EVENTS | 1.34e-03 | 39 | 79 | 3 | MM14496 | |
| Pathway | BIOCARTA_GABA_PATHWAY | 1.36e-03 | 10 | 79 | 2 | M477 | |
| Pathway | BIOCARTA_GABA_PATHWAY | 1.36e-03 | 10 | 79 | 2 | MM1401 | |
| Pathway | REACTOME_SUMOYLATION_OF_TRANSCRIPTION_COFACTORS | 1.44e-03 | 40 | 79 | 3 | MM15000 | |
| Pathway | KEGG_MEDICUS_REFERENCE_GENE_SILENCING_BY_METHYLATION_OF_H3K27_AND_UBIQUITINATION_OF_H2AK119 | 1.44e-03 | 40 | 79 | 3 | M47917 | |
| Pathway | REACTOME_DAG_AND_IP3_SIGNALING | 1.55e-03 | 41 | 79 | 3 | M512 | |
| Pathway | KEGG_MEDICUS_REFERENCE_LECTIN_PATHWAY_OF_COMPLEMENT_CASCADE_C4_C2_TO_C3_CONVERTASE_FORMATION | 1.65e-03 | 11 | 79 | 2 | M47874 | |
| Pathway | BIOCARTA_LECTIN_PATHWAY | 1.65e-03 | 11 | 79 | 2 | MM1430 | |
| Pathway | REACTOME_ADORA2B_MEDIATED_ANTI_INFLAMMATORY_CYTOKINES_PRODUCTION | 1.78e-03 | 43 | 79 | 3 | M29837 | |
| Pathway | REACTOME_VASOPRESSIN_REGULATES_RENAL_WATER_HOMEOSTASIS_VIA_AQUAPORINS | 1.78e-03 | 43 | 79 | 3 | M933 | |
| Pathway | REACTOME_GABA_B_RECEPTOR_ACTIVATION | 1.78e-03 | 43 | 79 | 3 | M954 | |
| Pathway | KEGG_ABC_TRANSPORTERS | 1.90e-03 | 44 | 79 | 3 | M11911 | |
| Pathway | REACTOME_GABA_B_RECEPTOR_ACTIVATION | 1.90e-03 | 44 | 79 | 3 | MM15709 | |
| Pathway | REACTOME_SUMOYLATION_OF_TRANSCRIPTION_COFACTORS | 1.90e-03 | 44 | 79 | 3 | M27295 | |
| Pathway | BIOCARTA_CLASSIC_PATHWAY | 1.97e-03 | 12 | 79 | 2 | MM1368 | |
| Pathway | KEGG_PURINE_METABOLISM | 1.97e-03 | 159 | 79 | 5 | M14314 | |
| Pathway | REACTOME_GPER1_SIGNALING | 2.03e-03 | 45 | 79 | 3 | M45008 | |
| Pathway | REACTOME_P75_NTR_RECEPTOR_MEDIATED_SIGNALLING | 2.13e-03 | 97 | 79 | 4 | M9400 | |
| Pathway | REACTOME_SUMOYLATION_OF_RNA_BINDING_PROTEINS | 2.30e-03 | 47 | 79 | 3 | M27395 | |
| Pathway | WP_KREBS_CYCLE_DISORDERS | 2.32e-03 | 13 | 79 | 2 | M39769 | |
| Pathway | BIOCARTA_LECTIN_PATHWAY | 2.32e-03 | 13 | 79 | 2 | M4732 | |
| Pathway | REACTOME_G_ALPHA_Z_SIGNALLING_EVENTS | 2.44e-03 | 48 | 79 | 3 | M10775 | |
| Pathway | REACTOME_DCC_MEDIATED_ATTRACTIVE_SIGNALING | 2.70e-03 | 14 | 79 | 2 | M889 | |
| Pathway | WP_PURINE_METABOLISM | 2.71e-03 | 171 | 79 | 5 | MM15909 | |
| Pathway | REACTOME_EPIGENETIC_REGULATION_OF_GENE_EXPRESSION | 2.99e-03 | 254 | 79 | 6 | M27131 | |
| Pathway | REACTOME_AQUAPORIN_MEDIATED_TRANSPORT | 3.07e-03 | 52 | 79 | 3 | M920 | |
| Pathway | BIOCARTA_CLASSIC_PATHWAY | 3.11e-03 | 15 | 79 | 2 | M7146 | |
| Pathway | REACTOME_NETRIN_1_SIGNALING | 3.11e-03 | 15 | 79 | 2 | MM14965 | |
| Pathway | REACTOME_G_PROTEIN_MEDIATED_EVENTS | 3.42e-03 | 54 | 79 | 3 | M26911 | |
| Pathway | WP_COMPLEMENT_ACTIVATION_CLASSICAL_PATHWAY | 3.99e-03 | 17 | 79 | 2 | MM15944 | |
| Pathway | BIOCARTA_COMP_PATHWAY | 3.99e-03 | 17 | 79 | 2 | MM1369 | |
| Pathway | REACTOME_SUMOYLATION_OF_RNA_BINDING_PROTEINS | 4.19e-03 | 58 | 79 | 3 | MM15149 | |
| Pathway | REACTOME_REGULATION_OF_PTEN_GENE_TRANSCRIPTION | 4.83e-03 | 61 | 79 | 3 | M27811 | |
| Pathway | REACTOME_CELLULAR_SENESCENCE | 4.95e-03 | 197 | 79 | 5 | M27188 | |
| Pathway | PID_ENDOTHELIN_PATHWAY | 5.28e-03 | 63 | 79 | 3 | M8 | |
| Pathway | REACTOME_OXIDATIVE_STRESS_INDUCED_SENESCENCE | 5.30e-03 | 125 | 79 | 4 | M27186 | |
| Pathway | BIOCARTA_COMP_PATHWAY | 5.52e-03 | 20 | 79 | 2 | M917 | |
| Pathway | REACTOME_SUMOYLATION_OF_CHROMATIN_ORGANIZATION_PROTEINS | 5.77e-03 | 65 | 79 | 3 | MM15147 | |
| Pathway | PID_LYSOPHOSPHOLIPID_PATHWAY | 5.77e-03 | 65 | 79 | 3 | M15 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | CDC42BPA TRIO MAP2 SLC22A23 RTN3 ADCY3 CEP170 EFHD1 ARID5B NT5C2 EHMT1 ANKRD17 TTC17 BOD1L1 EIF2AK4 PRDM15 CLEC16A UTRN ZMAT1 VAV2 | 9.03e-08 | 1489 | 115 | 20 | 28611215 |
| Pubmed | Isoforms of mammalian adenylyl cyclase: multiplicities of signaling. | 1.11e-07 | 14 | 115 | 4 | 14993377 | |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | ESRRA ESRRG CKAP5 EFHD2 C16orf96 AP3B1 PRPF8 TTK CEP170 EHMT1 EIF5B ANKRD17 GIGYF2 DCLRE1A | 1.30e-07 | 724 | 115 | 14 | 36232890 |
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | 3.92e-07 | 202 | 115 | 8 | 33005030 | |
| Pubmed | Mapping of adenylyl cyclase genes type I, II, III, IV, V, and VI in mouse. | 6.99e-07 | 6 | 115 | 3 | 7766992 | |
| Pubmed | Expression and regulation of adenylyl cyclase isoforms in the human adrenal gland. | 6.99e-07 | 6 | 115 | 3 | 11549699 | |
| Pubmed | CDC42BPA TRIO KALRN ESRRG CMYA5 ARMCX2 BIRC6 MAP3K5 CEP170 UTRN VAV2 | 8.50e-07 | 497 | 115 | 11 | 23414517 | |
| Pubmed | 1.22e-06 | 7 | 115 | 3 | 12613887 | ||
| Pubmed | 2.92e-06 | 9 | 115 | 3 | 12503609 | ||
| Pubmed | Role of the calcium modulated cyclases in the development of the retinal projections. | 2.92e-06 | 9 | 115 | 3 | 17229090 | |
| Pubmed | Purification and characterization of a soluble form of mammalian adenylyl cyclase. | 4.16e-06 | 10 | 115 | 3 | 8663304 | |
| Pubmed | 4.16e-06 | 10 | 115 | 3 | 16615126 | ||
| Pubmed | Mechanism of human immunodeficiency virus-induced complement expression in astrocytes and neurons. | 4.16e-06 | 10 | 115 | 3 | 11884542 | |
| Pubmed | CDC42BPA SF3A1 CKAP5 HLCS ABCC5 AP3B1 TTK CEP170 EIF5B ANKRD17 GIGYF2 BOD1L1 | 4.21e-06 | 708 | 115 | 12 | 39231216 | |
| Pubmed | 5.70e-06 | 11 | 115 | 3 | 10089566 | ||
| Pubmed | 5.70e-06 | 11 | 115 | 3 | 10808179 | ||
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | CDC42BPA TRIO MAP2 CKAP5 RAB11FIP1 TTK PPM1A CEP170 AASS ANKRD17 GIGYF2 BOD1L1 UTRN | 5.74e-06 | 861 | 115 | 13 | 36931259 |
| Pubmed | Several distinct polycomb complexes regulate and co-localize on the INK4a tumor suppressor locus. | 7.58e-06 | 12 | 115 | 3 | 19636380 | |
| Pubmed | 7.58e-06 | 12 | 115 | 3 | 10807185 | ||
| Pubmed | CDC42BPA ABCC5 AP3B1 BIRC6 PPL MKS1 CASP12 GLI3 EHMT1 DCLRE1A CLEC16A ZMAT1 | 1.07e-05 | 777 | 115 | 12 | 35844135 | |
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 22737222 | ||
| Pubmed | Deficiency of C4 from donor or recipient mouse fails to prevent renal allograft rejection. | 1.08e-05 | 2 | 115 | 2 | 16565498 | |
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 15998580 | ||
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 16681769 | ||
| Pubmed | Orphan nuclear receptor estrogen-related receptor alpha is essential for adaptive thermogenesis. | 1.08e-05 | 2 | 115 | 2 | 17229846 | |
| Pubmed | Structural polymorphism of murine C4 and its linkage to H-2. | 1.08e-05 | 2 | 115 | 2 | 7373044 | |
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 19062096 | ||
| Pubmed | The chemical structure of the C4d fragment of the human complement component C4. | 1.08e-05 | 2 | 115 | 2 | 3696167 | |
| Pubmed | Restriction fragment length polymorphism of the murine C4 and Slp genes: two C4 groups. | 1.08e-05 | 2 | 115 | 2 | 1357031 | |
| Pubmed | Structural comparison of human C4A3 and C4B1 after proteolytic activation by C1s. | 1.08e-05 | 2 | 115 | 2 | 16098595 | |
| Pubmed | Activation of innate and humoral immunity in the peripheral nervous system of ALS transgenic mice. | 1.08e-05 | 2 | 115 | 2 | 19933335 | |
| Pubmed | Structural basis for the C4d.1/C4d.2 serologic allotypes of murine complement component C4. | 1.08e-05 | 2 | 115 | 2 | 2459207 | |
| Pubmed | Antigen-induced B cell apoptosis is independent of complement C4. | 1.08e-05 | 2 | 115 | 2 | 17645767 | |
| Pubmed | Increased frequency of C4B*Q0 alleles in patients with Henoch-Schönlein purpura. | 1.08e-05 | 2 | 115 | 2 | 15787745 | |
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 12207352 | ||
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 25624346 | ||
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 30026462 | ||
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 6559257 | ||
| Pubmed | Genome-wide orchestration of cardiac functions by the orphan nuclear receptors ERRalpha and gamma. | 1.08e-05 | 2 | 115 | 2 | 17488637 | |
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 21244694 | ||
| Pubmed | Complement C4A and C4B Gene Copy Number Study in Alzheimer's Disease Patients. | 1.08e-05 | 2 | 115 | 2 | 27758680 | |
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 22387014 | ||
| Pubmed | Complement C4 Is Reduced in iPSC-Derived Astrocytes of Autism Spectrum Disorder Subjects. | 1.08e-05 | 2 | 115 | 2 | 34299197 | |
| Pubmed | Assessment of complement C4 gene copy number using the paralog ratio test. | 1.08e-05 | 2 | 115 | 2 | 20506482 | |
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 18164588 | ||
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 12480675 | ||
| Pubmed | Signaling pathways for modulation of mouse sperm motility by adenosine and catecholamine agonists. | 1.08e-05 | 2 | 115 | 2 | 16291925 | |
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 18085262 | ||
| Pubmed | Repression of osteoblast maturation by ERRα accounts for bone loss induced by estrogen deficiency. | 1.08e-05 | 2 | 115 | 2 | 23359549 | |
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 26800705 | ||
| Pubmed | Complement C4 maintains peripheral B-cell tolerance in a myeloid cell dependent manner. | 1.08e-05 | 2 | 115 | 2 | 23749435 | |
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 23918728 | ||
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 21073549 | ||
| Pubmed | Murine complement C4 is not required for experimental autoimmune encephalomyelitis. | 1.08e-05 | 2 | 115 | 2 | 15390104 | |
| Pubmed | Molecular genetics of androgen-dependent and -independent expression of mouse sex-limited protein. | 1.08e-05 | 2 | 115 | 2 | 3037333 | |
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 12384788 | ||
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 11726230 | ||
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 4216347 | ||
| Pubmed | Importance of the alpha 3-fragment of complement C4 for the binding with C4b-binding protein. | 1.08e-05 | 2 | 115 | 2 | 1699796 | |
| Pubmed | Sequence determination of the thiolester site of the fourth component of human complement. | 1.08e-05 | 2 | 115 | 2 | 6950384 | |
| Pubmed | Molecular cloning and characterization of complementary and genomic DNA clones for mouse C4 and Slp. | 1.08e-05 | 2 | 115 | 2 | 2997024 | |
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 23109109 | ||
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 8660986 | ||
| Pubmed | Constitutive expression of Slp genes in mouse strain B10.WR directed by C4 regulatory sequences. | 1.08e-05 | 2 | 115 | 2 | 3624865 | |
| Pubmed | Tissue-specific RNA processing for the complement C4 gene transcript in the H-2k mouse strain. | 1.08e-05 | 2 | 115 | 2 | 8428773 | |
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 21857912 | ||
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 24638111 | ||
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 6208559 | ||
| Pubmed | The role of the histocompatibility-2-linked Ss-Slp region in the control of mouse complement. | 1.08e-05 | 2 | 115 | 2 | 4514997 | |
| Pubmed | Transcriptional repression of C4 complement by hepatitis C virus proteins. | 1.08e-05 | 2 | 115 | 2 | 21345967 | |
| Pubmed | The inheritance of susceptibility to the Gross leukemia virus in mice. | 1.08e-05 | 2 | 115 | 2 | 5919331 | |
| Pubmed | An ancient provirus has imposed androgen regulation on the adjacent mouse sex-limited protein gene. | 1.08e-05 | 2 | 115 | 2 | 3167981 | |
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 7545960 | ||
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 30041577 | ||
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 2572548 | ||
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 2302180 | ||
| Pubmed | Complete cDNA sequence of the fourth component of murine complement. | 1.08e-05 | 2 | 115 | 2 | 3862104 | |
| Pubmed | The BS variant of C4 protects against age-related loss of white matter microstructural integrity. | 1.08e-05 | 2 | 115 | 2 | 34358307 | |
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 15256438 | ||
| Pubmed | Acute renal allograft rejection: diagnostic significance of focal peritubular capillary C4d. | 1.08e-05 | 2 | 115 | 2 | 18360261 | |
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 22151770 | ||
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 19822186 | ||
| Pubmed | C4d-positive chronic rejection: a frequent entity with a poor outcome. | 1.08e-05 | 2 | 115 | 2 | 18091514 | |
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 29080553 | ||
| Pubmed | Schizophrenia risk from complex variation of complement component 4. | 1.08e-05 | 2 | 115 | 2 | 26814963 | |
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 6589636 | ||
| Pubmed | C4 Deficiency is a predisposing factor for Streptococcus pneumoniae-induced autoantibody production. | 1.08e-05 | 2 | 115 | 2 | 25339671 | |
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 17728371 | ||
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 6149580 | ||
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 6149581 | ||
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 21056629 | ||
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 12115608 | ||
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 3542363 | ||
| Pubmed | PMS2 or PMS2CL? Characterization of variants detected in the 3' of the PMS2 gene. | 1.08e-05 | 2 | 115 | 2 | 37534630 | |
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 2387317 | ||
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 8132550 | ||
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 2395880 | ||
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 26814708 | ||
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 6192448 | ||
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 18973555 | ||
| Interaction | CTAGE1 interactions | 1.85e-07 | 10 | 112 | 4 | int:CTAGE1 | |
| Interaction | LRRC31 interactions | 1.92e-05 | 205 | 112 | 8 | int:LRRC31 | |
| Interaction | KCNA3 interactions | ADCY10 CDC42BPA ABCA13 SF3A1 CKAP5 HLCS ABCC5 AP3B1 TTK PPL CEP170 EIF5B ANKRD17 GIGYF2 BOD1L1 EIF2AK4 | 2.52e-05 | 871 | 112 | 16 | int:KCNA3 |
| Cytoband | 7q35 | 1.15e-05 | 55 | 115 | 4 | 7q35 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr7q35 | 2.39e-05 | 66 | 115 | 4 | chr7q35 | |
| Cytoband | 17q22 | 1.88e-04 | 44 | 115 | 3 | 17q22 | |
| Cytoband | 2p22.1 | 7.29e-04 | 16 | 115 | 2 | 2p22.1 | |
| GeneFamily | CTAGE family | 4.62e-09 | 15 | 81 | 5 | 907 | |
| GeneFamily | Adenylate cyclases|Deafness associated genes | 7.69e-08 | 10 | 81 | 4 | 53 | |
| GeneFamily | Ankyrin repeat domain containing | 1.27e-05 | 242 | 81 | 8 | 403 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 2.18e-04 | 66 | 81 | 4 | 722 | |
| GeneFamily | C3 and PZP like, alpha-2-macroglobulin domain containing | 6.99e-04 | 9 | 81 | 2 | 1234 | |
| GeneFamily | Gamma-aminobutyric acid type A receptor subunits | 3.23e-03 | 19 | 81 | 2 | 563 | |
| GeneFamily | Mitogen-activated protein kinase kinase kinases|RAF family | 5.13e-03 | 24 | 81 | 2 | 654 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.76e-06 | 160 | 115 | 6 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.76e-06 | 160 | 115 | 6 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | Mid-temporal_gyrus_(MTG)|World / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.94e-06 | 178 | 115 | 6 | ad187db4c40b9078d54dd915c143e0172b2f47b8 | |
| ToppCell | TCGA-Mesothelium-Primary_Tumor-Mesothelioma-Epitheliod|TCGA-Mesothelium / Sample_Type by Project: Shred V9 | 7.88e-06 | 182 | 115 | 6 | bb1f815718397de96682697fcbd6014a992a28f7 | |
| ToppCell | RV-07._Pericyte|World / Chamber and Cluster_Paper | 9.19e-06 | 187 | 115 | 6 | dc274d6bbda619a2c914d84e2b4069cfef1739d1 | |
| ToppCell | COPD-Lymphoid-B|Lymphoid / Disease state, Lineage and Cell class | 1.01e-05 | 190 | 115 | 6 | 1e85ee686ff6dd27c69415d524d54fa825b1daad | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.13e-05 | 194 | 115 | 6 | ebb038f94f49f5c655578d1b018676e10c6b7e3c | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.20e-05 | 196 | 115 | 6 | b8759e6231e0254797d6c30930407b79440c57bb | |
| ToppCell | Non-neuronal-Non-dividing-Radial_Glia-tRG|World / Primary Cells by Cluster | 1.24e-05 | 197 | 115 | 6 | 61749ccafeb938c310cff1de5ff924a1c794325a | |
| ToppCell | Bronchial-NucSeq-Stromal-Peri/Epineurial_-NAF_epineurial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.24e-05 | 197 | 115 | 6 | dfeb4a0eb4dfba90f4a3e6ba31e0ab0e4aba5849 | |
| ToppCell | Non-neuronal-Non-dividing-Radial_Glia-tRG-25|World / Primary Cells by Cluster | 1.24e-05 | 197 | 115 | 6 | 9d4ffa3680f92c91d0a081f9a8ec5ebfec6bdcf6 | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.27e-05 | 198 | 115 | 6 | cc2b5b632e73e44bb60050f0db10d8f0dbb859fa | |
| ToppCell | Bronchial-NucSeq-Stromal-Chondrocytic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.35e-05 | 200 | 115 | 6 | b7b9441fa7ab0d43741a2ebd5ec1a48d537c6d47 | |
| ToppCell | Bronchial-NucSeq-Stromal-Chondrocytic-Chondrocyte|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.35e-05 | 200 | 115 | 6 | 7c673ad0ea503ebd196579684d25d5f9e6a41030 | |
| ToppCell | VE-Treg-naive_CD4|VE / Condition, Cell_class and T cell subcluster | 5.30e-05 | 156 | 115 | 5 | 6501baf73616e702946de9fb13d267e30a68888b | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-Tregs|GI_small-bowel / Manually curated celltypes from each tissue | 5.47e-05 | 157 | 115 | 5 | c44bd530e396b08f16f284e185dcb830843959ea | |
| ToppCell | Basal_cells-IPF_04|World / lung cells shred on cell class, cell subclass, sample id | 6.53e-05 | 163 | 115 | 5 | 679e25e5548d157d49a73057a3b5617dccda260f | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.92e-05 | 165 | 115 | 5 | 62457b7b74c6eae42d91d65e7dc6df6bf8e061f7 | |
| ToppCell | ASK452-Epithelial-Type_2|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq | 6.99e-05 | 85 | 115 | 4 | 523a532e91aa271faab67d0256919b67af2bd7d8 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-5_RORB_HSPB3|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.97e-05 | 170 | 115 | 5 | 985c6c9e3c593ed0628a481f06c2c91b2ab5d746 | |
| ToppCell | droplet-Skin-nan-18m-Epithelial-keratinocyte_stem_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.97e-05 | 170 | 115 | 5 | 10e0912dd0beab5d0bbe2bd49e477b5962687925 | |
| ToppCell | Control-Epithelial_cells-Airway_basal|Control / group, cell type (main and fine annotations) | 8.19e-05 | 171 | 115 | 5 | 3965ced4be6db14265a90673502fceee425837ca | |
| ToppCell | saliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Granulocytic|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.19e-05 | 171 | 115 | 5 | 2b7c5a557c4bc5c573211c4d618bdd6766a24916 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Granulocytic-Neutrophil|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.19e-05 | 171 | 115 | 5 | dcb15bc54aeea06ef8f07f1134f3ff1e21ac0e4f | |
| ToppCell | 356C-Lymphocytic-ILC-ILC-2|ILC / Donor, Lineage, Cell class and subclass (all cells) | 8.42e-05 | 172 | 115 | 5 | 4977e1f4deae781750e27a8054deccd336cfb74a | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 9.13e-05 | 175 | 115 | 5 | 316f2ea930437bf1243b1c0f45e6bd864112c6f2 | |
| ToppCell | facs-Large_Intestine-Distal-18m-Epithelial-Brush_cell_of_epithelium_proper_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.13e-05 | 175 | 115 | 5 | f24b664b9056b5976bf2222e8013f15c09e049ad | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 9.13e-05 | 175 | 115 | 5 | a9f08e1e4c2997dcdd3e5d92daac480da19100b8 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.89e-05 | 178 | 115 | 5 | 0e1bedf991189d0ef9b40dac9281bdf4739333a1 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_FAM95C|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.02e-04 | 179 | 115 | 5 | f65889bf1e41396979cce44a5e63f49dea2bbd9b | |
| ToppCell | RA-07._Pericyte|RA / Chamber and Cluster_Paper | 1.07e-04 | 181 | 115 | 5 | 8dfb42d096db6c2df9b41303a7199d134d4bff07 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.07e-04 | 181 | 115 | 5 | aa233b652921848af2257cc3687a7a09c3acfb67 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.10e-04 | 182 | 115 | 5 | 5f513bbb7125956eb528e3120de3fd776770a7c3 | |
| ToppCell | LA-07._Pericyte|World / Chamber and Cluster_Paper | 1.13e-04 | 183 | 115 | 5 | e3835db4795362b0442d5893baf2a78efcc20428 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.13e-04 | 183 | 115 | 5 | 65f2a5895d166189a095cf7ea9dda171f0419b08 | |
| ToppCell | nucseq-Immune-Lymphocytic_B-Lymphocytic_B-Plasma|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.19e-04 | 185 | 115 | 5 | 3b77bc49cd3740acc025e162a36282ac09e12198 | |
| ToppCell | COPD-Lymphoid-T_Regulatory|COPD / Disease state, Lineage and Cell class | 1.19e-04 | 185 | 115 | 5 | 846403edd4c8f646201d519055198fc38b7ffff9 | |
| ToppCell | Control-Lymphoid-T_Regulatory|Lymphoid / Disease state, Lineage and Cell class | 1.19e-04 | 185 | 115 | 5 | e481cacda0b6b25f5f0062b962df9a442053ac30 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.22e-04 | 186 | 115 | 5 | f0c8de4f6ae9047b9108a47a2af8c5f42bc103b0 | |
| ToppCell | RV-07._Pericyte|RV / Chamber and Cluster_Paper | 1.22e-04 | 186 | 115 | 5 | c533b264fbe12bc35467486fc7fbde24ba968fe1 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-pericyte_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.25e-04 | 187 | 115 | 5 | 86250acf088ec0c4800a0dfa031b0d4f7e52c342 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Degenerative_Descending_Thin_Limb_Cell_Type_3|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.25e-04 | 187 | 115 | 5 | c31130fc2f9f882944b2ba366a034a03f051c4b9 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 1.31e-04 | 189 | 115 | 5 | a48df46274d51e84ffb40264646de7346104efb9 | |
| ToppCell | COPD-Lymphoid-T_Regulatory|Lymphoid / Disease state, Lineage and Cell class | 1.38e-04 | 191 | 115 | 5 | 3ae18bc4e3dff49b5d5958da8ebc3f747274b69c | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.38e-04 | 191 | 115 | 5 | fa380a8752de158974b2ae5e741573439719cc0d | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.38e-04 | 191 | 115 | 5 | 04c4d454b57e29a8d1dcdeb4678ce71bdc29b77b | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.38e-04 | 191 | 115 | 5 | 7b0d42a877540dbb346a76a62403e0d5d3e07fa6 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.38e-04 | 191 | 115 | 5 | cd854b9c426924fdc84bf7f411f6dea447143e79 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.44e-04 | 193 | 115 | 5 | 08696a99309f5b088692ddac8cca35413b5e810d | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 1.44e-04 | 193 | 115 | 5 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | COVID-19-lung-Pericytes/_Smooth_Muscle|lung / Disease (COVID-19 only), tissue and cell type | 1.48e-04 | 194 | 115 | 5 | 5e1e0513a54ec4cf0b247ec85c9fbc68dfac1da3 | |
| ToppCell | droplet-Mammary_Gland-nan-3m-Epithelial-luminal_progenitor_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.55e-04 | 196 | 115 | 5 | 22fcfb713f402ebbd43b2822f0fd919cdbfba6e4 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.55e-04 | 196 | 115 | 5 | f40d10ea7714067585493fdc89744714aa427de8 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Degenerative_Distal_Convoluted_Tubule_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.55e-04 | 196 | 115 | 5 | b8350340d86e4524e9616a427e7f2e116a6fb3be | |
| ToppCell | Parenchymal-10x5prime-Stromal-Mesofibroblastic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.59e-04 | 197 | 115 | 5 | 88a86286b9c3ea3b076d7464faec42d0392ee7f8 | |
| ToppCell | Parenchymal-10x5prime-Stromal-Mesofibroblastic-Mesothelia|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.59e-04 | 197 | 115 | 5 | 2773d2eb5f232a7e49da116efffcb6bf5eb90810 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_basal-Basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.59e-04 | 197 | 115 | 5 | 1e915957ea6a4550ecb9d6ee4b232aa5800faf20 | |
| ToppCell | Bronchus_Control_(B.)|World / Sample group, Lineage and Cell type | 1.59e-04 | 197 | 115 | 5 | b6dff2ee108813e18657e2d8cf850e2423f8c8e9 | |
| ToppCell | Biopsy_Other_PF-Mesenchymal-Mesothelial_cells|Biopsy_Other_PF / Sample group, Lineage and Cell type | 1.63e-04 | 198 | 115 | 5 | 86736f01e61bf4961f060b24ee1f1f48340737dd | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.63e-04 | 198 | 115 | 5 | c01091ef18e096d792ea2a7a715764a5b215355f | |
| ToppCell | Bronchial-10x5prime-Stromal-Peri/Epineurial_-NAF_epineurial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.67e-04 | 199 | 115 | 5 | a13f4b8a039304e685464cc8879659824cad5a3e | |
| ToppCell | (02)_MMP9/10+-(2)_GFP_FOXI1|(02)_MMP9/10+ / shred by cell type by condition | 1.67e-04 | 199 | 115 | 5 | 18a7f9ced4364f45b184bd529f32ef02c27779d3 | |
| ToppCell | Bronchial-10x5prime-Stromal-Peri/Epineurial_|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.67e-04 | 199 | 115 | 5 | 45c3b853900d8c3d5965117d904e3714100138bc | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 1.67e-04 | 199 | 115 | 5 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | 1.67e-04 | 199 | 115 | 5 | c425e7975f492ed5cfcca022248adb627e1d27d4 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.67e-04 | 199 | 115 | 5 | b1753474152b82a0b811b9878c890a359e14919a | |
| ToppCell | (01)_IL1RL1+-(2)_GFP_FOXI1|(01)_IL1RL1+ / shred by cell type by condition | 1.67e-04 | 199 | 115 | 5 | a2f7d0cabf35b80fe239fae34a77bf9344d5d743 | |
| ToppCell | Neuronal-Excitatory-eD(FEZF2)|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.71e-04 | 200 | 115 | 5 | 1b485ff2435c6732be58cbc9eb2f5c273f9c4bf2 | |
| ToppCell | Tracheal|World / Cell types per location group and 10X technology with lineage, and cell group designations | 1.71e-04 | 200 | 115 | 5 | 682960e28542a3d6c119047cd0131941932cfdea | |
| ToppCell | Parenchymal-10x5prime-Stromal-Peri/Epineurial_-NAF_epineurial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.71e-04 | 200 | 115 | 5 | 36de49593cf6ff1c9229fcceb150c1d68658a360 | |
| Drug | NSC-4928 | 3.66e-07 | 58 | 110 | 6 | CID000221086 | |
| Drug | DPDPE | 2.88e-06 | 82 | 110 | 6 | CID000104787 | |
| Drug | baclofen | 4.18e-06 | 191 | 110 | 8 | CID000002284 | |
| Drug | prenalterol | 9.66e-06 | 28 | 110 | 4 | CID000042396 | |
| Drug | desacetylnantradol | 9.66e-06 | 28 | 110 | 4 | CID000125211 | |
| Drug | etazolate | 1.12e-05 | 29 | 110 | 4 | CID000003277 | |
| Drug | 2',5'-dd3'-FSBA | 1.28e-05 | 10 | 110 | 3 | CID003081206 | |
| Drug | NC-5Z | 1.28e-05 | 10 | 110 | 3 | CID003035914 | |
| Drug | AC1L2FXT | 1.28e-05 | 10 | 110 | 3 | CID000071316 | |
| Drug | adenosine analog | 1.46e-05 | 64 | 110 | 5 | CID000469074 | |
| Drug | AAGTP | 1.46e-05 | 64 | 110 | 5 | CID000656407 | |
| Drug | MDL-12330A | 1.70e-05 | 66 | 110 | 5 | CID000004024 | |
| Drug | AC1L40QM | 1.76e-05 | 11 | 110 | 3 | CID000099213 | |
| Drug | B-Mlvp | 1.76e-05 | 11 | 110 | 3 | CID000195648 | |
| Drug | AC1NY9KD | 1.76e-05 | 11 | 110 | 3 | CID005771741 | |
| Drug | AC1L2XIZ | 2.34e-05 | 12 | 110 | 3 | CID000104803 | |
| Drug | sulprostone | 2.43e-05 | 71 | 110 | 5 | CID005312153 | |
| Drug | L-quisqualic acid | 2.75e-05 | 180 | 110 | 7 | CID000001209 | |
| Drug | AC1NPJ0Q | 2.97e-05 | 74 | 110 | 5 | CID005159167 | |
| Drug | FCE 23884 | 3.03e-05 | 13 | 110 | 3 | CID000065898 | |
| Drug | 2g6p | 3.35e-05 | 38 | 110 | 4 | CID002740174 | |
| Drug | Beraprost-d3 | 3.60e-05 | 77 | 110 | 5 | CID000002352 | |
| Drug | methiothepin | 3.60e-05 | 77 | 110 | 5 | CID000004106 | |
| Drug | NSC759576 | 4.02e-05 | 191 | 110 | 7 | CID000003075 | |
| Drug | N6-(phenylisopropyl)adenosine | 4.55e-05 | 41 | 110 | 4 | CID000034507 | |
| Drug | Hydrochlorothiazide [58-93-5]; Down 200; 13.4uM; MCF7; HT_HG-U133A | 4.74e-05 | 196 | 110 | 7 | 1487_DN | |
| Drug | TBOB | 4.79e-05 | 15 | 110 | 3 | CID000114986 | |
| Drug | BMY 42393 | 4.79e-05 | 15 | 110 | 3 | CID000131961 | |
| Drug | atropine sulfate | 4.81e-05 | 347 | 110 | 9 | CID000003661 | |
| Drug | 1 Em | 5.17e-05 | 83 | 110 | 5 | CID000446621 | |
| Drug | brimonidine | 6.13e-05 | 86 | 110 | 5 | CID000002435 | |
| Drug | AC1LD8Z3 | 6.13e-05 | 86 | 110 | 5 | CID000644309 | |
| Drug | dobutamine | 6.15e-05 | 140 | 110 | 6 | CID000036811 | |
| Drug | Zolpidem | 6.92e-05 | 3 | 110 | 2 | DB00425 | |
| Drug | 2-aminothiophenol | 6.92e-05 | 3 | 110 | 2 | ctd:C005464 | |
| Drug | delta-aminovaleric acid | 7.84e-05 | 47 | 110 | 4 | CID000000138 | |
| Drug | lormetazepam | 8.49e-05 | 18 | 110 | 3 | CID000013314 | |
| Drug | edrophonium | 8.52e-05 | 48 | 110 | 4 | CID000003202 | |
| Drug | pirenzepine | 8.90e-05 | 93 | 110 | 5 | CID000004848 | |
| Drug | hydroxyzine | 1.00e-04 | 19 | 110 | 3 | CID000003658 | |
| Drug | Ro 41-9067 | 1.00e-04 | 19 | 110 | 3 | CID000125800 | |
| Drug | AC1O4WK7 | 1.00e-04 | 19 | 110 | 3 | CID006420129 | |
| Drug | SK&F 82958 | 1.00e-04 | 19 | 110 | 3 | ctd:C071262 | |
| Drug | guanosine 3',5'-cyclic monophosphoric acid | ADCY10 ABCC5 DCC ADCY2 ADCY3 ADCY5 PHC1 PHC2 GLI3 NT5C2 ART5 | 1.11e-04 | 577 | 110 | 11 | CID000000295 |
| Drug | morphine hydrochloride | ADCY10 ABCB5 ESRRA ESRRG ADCY2 ADCY3 ADCY5 ART5 GABRA1 GABRA2 | 1.15e-04 | 481 | 110 | 10 | CID000004253 |
| Drug | isocycloheximide | POMT2 COL11A1 ERN1 ESRRA ESRRG ABCC5 BIRC6 ADCY2 ADCY3 ADCY5 EIF5B EIF2AK4 ART5 PCK2 | 1.18e-04 | 905 | 110 | 14 | CID000002900 |
| Drug | triazolam | 1.35e-04 | 54 | 110 | 4 | CID000005556 | |
| Drug | reproterol | 1.37e-04 | 21 | 110 | 3 | CID000025654 | |
| Drug | Flumazenil | 1.38e-04 | 4 | 110 | 2 | DB01205 | |
| Drug | tert-butylbicyclo-2-benzoate | 1.38e-04 | 4 | 110 | 2 | ctd:C046308 | |
| Drug | AC1MUNZL | 1.56e-04 | 56 | 110 | 4 | CID003643892 | |
| Drug | GSK835726 | 1.58e-04 | 22 | 110 | 3 | CID005311268 | |
| Drug | endrine | 1.65e-04 | 106 | 110 | 5 | CID000003048 | |
| Drug | trequinsin | 1.79e-04 | 58 | 110 | 4 | CID000005537 | |
| Drug | beta-CNA | 1.81e-04 | 23 | 110 | 3 | CID005486190 | |
| Drug | Scpb | 1.81e-04 | 23 | 110 | 3 | CID000123843 | |
| Drug | zolazepam | 1.81e-04 | 23 | 110 | 3 | CID000035775 | |
| Drug | etorphine | 1.91e-04 | 59 | 110 | 4 | CID000026721 | |
| Drug | SKF 38393 | 1.96e-04 | 110 | 110 | 5 | CID000001242 | |
| Drug | NAIN | 2.06e-04 | 24 | 110 | 3 | CID000195228 | |
| Drug | TL-99 | 2.06e-04 | 24 | 110 | 3 | CID000122132 | |
| Drug | trimetoquinol | 2.06e-04 | 24 | 110 | 3 | CID000005581 | |
| Drug | AC1L8VEV | 2.06e-04 | 24 | 110 | 3 | CID000433433 | |
| Drug | TMB-8 | 2.16e-04 | 176 | 110 | 6 | CID000005494 | |
| Drug | 9-beta-D-arabinofuranosylguanine | PCYT1A TRIO ADCY2 ADCY3 ADCY5 PPL NT5C2 EIF5B C4A EIF2AK4 ART5 VAV2 PCK2 | 2.16e-04 | 843 | 110 | 13 | CID000000765 |
| Drug | otenzepad | 2.18e-04 | 61 | 110 | 4 | CID000107867 | |
| Drug | glutamate | MAP2 ABCB5 NPAS3 HLCS ADCY2 ADCY3 ADCY5 APIP AASS FH ART5 PCK2 GABRA1 GABRA2 | 2.22e-04 | 962 | 110 | 14 | CID000000611 |
| Drug | Eszopiclone | 2.29e-04 | 5 | 110 | 2 | DB00402 | |
| Drug | Quinidine barbiturate | 2.29e-04 | 5 | 110 | 2 | DB01346 | |
| Drug | Zopiclone | 2.29e-04 | 5 | 110 | 2 | DB01198 | |
| Drug | alphaxalone | 2.29e-04 | 5 | 110 | 2 | ctd:C006477 | |
| Drug | tert-butylbicyclophosphorothionate | 2.29e-04 | 5 | 110 | 2 | ctd:C037476 | |
| Drug | Lorazepam | 2.29e-04 | 5 | 110 | 2 | ctd:D008140 | |
| Drug | 8-phenyltheophylline | 2.32e-04 | 62 | 110 | 4 | CID000001922 | |
| Drug | PD 81,723 | 2.34e-04 | 25 | 110 | 3 | CID000122028 | |
| Drug | octimibate | 2.34e-04 | 25 | 110 | 3 | CID000065676 | |
| Drug | manganese-ATP | 2.34e-04 | 25 | 110 | 3 | CID000124341 | |
| Drug | cimetidine | 2.37e-04 | 179 | 110 | 6 | CID000002756 | |
| Drug | phenoxybenzamine | 2.42e-04 | 115 | 110 | 5 | CID000004768 | |
| Drug | propranolol | 2.60e-04 | 434 | 110 | 9 | CID000004946 | |
| Drug | 8-OH-DPAT | 2.62e-04 | 117 | 110 | 5 | CID000001220 | |
| Drug | alprenolol | 2.62e-04 | 64 | 110 | 4 | CID000002119 | |
| Drug | xanthine amine congener | 2.62e-04 | 64 | 110 | 4 | CID000005697 | |
| Drug | metaproterenol | 2.63e-04 | 26 | 110 | 3 | CID000004086 | |
| Drug | 17-DMAG; Up 200; 0.1uM; MCF7; HT_HG-U133A_EA | 2.74e-04 | 184 | 110 | 6 | 1051_UP | |
| Drug | AC1Q4Y39 | 2.78e-04 | 65 | 110 | 4 | CID000004402 | |
| Drug | SM-10906 | 2.95e-04 | 27 | 110 | 3 | CID006442261 | |
| Drug | 2-propylpentanoic acid; Up 200; 1000uM; MCF7; HT_HG-U133A_EA | 2.99e-04 | 187 | 110 | 6 | 1047_UP | |
| Drug | AC1L1HE1 | 3.13e-04 | 67 | 110 | 4 | CID000004090 | |
| Drug | diazepam | 3.17e-04 | 189 | 110 | 6 | CID000003016 | |
| Drug | atenolol | 3.18e-04 | 122 | 110 | 5 | CID000002249 | |
| Drug | 3-isoreserpine | 3.26e-04 | 190 | 110 | 6 | CID000005052 | |
| Drug | tetrahydrofurfuryl alcohol | 3.29e-04 | 28 | 110 | 3 | CID000007360 | |
| Drug | Nocloprostum | 3.29e-04 | 28 | 110 | 3 | CID006435380 | |
| Drug | probenecid | 3.30e-04 | 123 | 110 | 5 | CID000004911 | |
| Drug | Meprobamate | 3.43e-04 | 6 | 110 | 2 | DB00371 | |
| Drug | centperazine | 3.43e-04 | 6 | 110 | 2 | CID000160000 | |
| Drug | jatrorrhizine | 3.43e-04 | 6 | 110 | 2 | CID000072323 | |
| Drug | AG-013608 [351320-38-2]; Down 200; 10uM; MCF7; HT_HG-U133A | 3.44e-04 | 192 | 110 | 6 | 6435_DN | |
| Drug | Carbamazepine [298-46-4]; Down 200; 17uM; PC3; HT_HG-U133A | 3.54e-04 | 193 | 110 | 6 | 1805_DN | |
| Disease | Colorectal Carcinoma | PMS2 SALL3 MAP2 KALRN ABCA13 SF3A1 ABCB5 ABCC5 DCC F5 GLI3 PDZRN4 | 7.76e-06 | 702 | 105 | 12 | C0009402 |
| Disease | neuroticism measurement, cognitive function measurement | KALRN SLC22A23 ESRRG DCC BIRC6 ADCY2 ADCY3 PHF20L1 GABRA1 GABRA2 | 3.52e-05 | 566 | 105 | 10 | EFO_0007660, EFO_0008354 |
| Disease | polycystic ovary syndrome, fasting blood glucose measurement | 3.75e-05 | 3 | 105 | 2 | EFO_0000660, EFO_0004465 | |
| Disease | azoospermia (implicated_via_orthology) | 1.20e-04 | 27 | 105 | 3 | DOID:14227 (implicated_via_orthology) | |
| Disease | Lupus Erythematosus, Systemic | 1.22e-04 | 71 | 105 | 4 | C0024141 | |
| Disease | amphetamine abuse (implicated_via_orthology) | 1.86e-04 | 6 | 105 | 2 | DOID:670 (implicated_via_orthology) | |
| Disease | peripheral neuropathy, response to bortezomib | 1.86e-04 | 6 | 105 | 2 | EFO_0003100, EFO_0007808 | |
| Disease | cerebral infarction (implicated_via_orthology) | 1.86e-04 | 6 | 105 | 2 | DOID:3526 (implicated_via_orthology) | |
| Disease | seasonal allergic rhinitis | 2.01e-04 | 32 | 105 | 3 | EFO_0003956 | |
| Disease | androsterone sulfate measurement | 2.21e-04 | 33 | 105 | 3 | EFO_0021117 | |
| Disease | asthma, response to diisocyanate | 3.50e-04 | 261 | 105 | 6 | EFO_0006995, MONDO_0004979 | |
| Disease | cancer (implicated_via_orthology) | 4.03e-04 | 268 | 105 | 6 | DOID:162 (implicated_via_orthology) | |
| Disease | anxiety disorder, stress-related disorder | 8.09e-04 | 12 | 105 | 2 | EFO_0006788, EFO_0010098 | |
| Disease | smoking status measurement | CDC42BPA ESRRG NPAS3 DCC BIRC6 ADCY2 ADCY3 PHC2 ARID5B NT5C2 UTRN PCK2 | 8.69e-04 | 1160 | 105 | 12 | EFO_0006527 |
| Disease | tetralogy of Fallot (implicated_via_orthology) | 1.11e-03 | 14 | 105 | 2 | DOID:6419 (implicated_via_orthology) | |
| Disease | smoking behavior | 1.41e-03 | 341 | 105 | 6 | EFO_0004318 | |
| Disease | systemic lupus erythematosus (is_implicated_in) | 1.42e-03 | 62 | 105 | 3 | DOID:9074 (is_implicated_in) | |
| Disease | response to haloperidol | 1.46e-03 | 16 | 105 | 2 | GO_1905119 | |
| Disease | risk-taking behaviour | 1.64e-03 | 764 | 105 | 9 | EFO_0008579 | |
| Disease | Major Depressive Disorder | 1.80e-03 | 243 | 105 | 5 | C1269683 | |
| Disease | nephrotic syndrome | 2.10e-03 | 71 | 105 | 3 | EFO_0004255 | |
| Disease | attention deficit hyperactivity disorder, substance abuse, antisocial behaviour measurement | 2.26e-03 | 801 | 105 | 9 | EFO_0003888, EFO_0007052, MONDO_0002491 | |
| Disease | Unipolar Depression | 2.37e-03 | 259 | 105 | 5 | C0041696 | |
| Disease | venous thromboembolism, plasminogen activator inhibitor 1 measurement | 2.52e-03 | 21 | 105 | 2 | EFO_0004286, EFO_0004792 | |
| Disease | nucleus accumbens volume | 2.77e-03 | 22 | 105 | 2 | EFO_0006931 | |
| Disease | attention deficit hyperactivity disorder, autism spectrum disorder, intelligence | 3.04e-03 | 398 | 105 | 6 | EFO_0003756, EFO_0003888, EFO_0004337 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| ASKMKNMEGSDPAHI | 371 | Q8NDB2 | |
| SLGHRPSQEMDKMLK | 466 | Q5SW79 | |
| HRIKEMKQMHPNGEA | 516 | Q8IVF6 | |
| GKPSLVDLNEEMQHM | 1146 | Q9NR09 | |
| GHLPMMKDQAAVLEE | 271 | Q8IX94 | |
| GHLPMMKDQAAVLEE | 271 | Q86UF2 | |
| GHLPMMKDQAAVLEE | 271 | P0CG41 | |
| GHLPMMKDQAAVLEE | 271 | A4FU28 | |
| GHLPMMKDQAAVLEE | 271 | A4D2H0 | |
| HKPLNMGKVFEAMNS | 616 | P0C0L5 | |
| NMGSPDQLMVHKGKC | 271 | Q9P2K8 | |
| NAADMPANMDKHALK | 11 | P49902 | |
| KDGMLAEKGAHAELM | 596 | Q2M3G0 | |
| HPVALNFMKGCLKMN | 256 | Q5MAI5 | |
| HLVMKLSYGPEEKDM | 821 | Q9UDR5 | |
| MEKTKTKQGENEHMP | 1 | A8MVX0 | |
| RIKEMKQMHPNGEAK | 526 | A2A2Z9 | |
| MIHKAAIAGDVNKVM | 41 | A6NC57 | |
| LAEEIHGMMDKAKNL | 121 | Q86UQ4 | |
| LPRHVAMEMKADINA | 436 | O95622 | |
| VMAMEHIFNLPLKGE | 1276 | Q96PN6 | |
| PLMLAAMNGHTAAVK | 1221 | O75179 | |
| MADEKPSNGVLVHMV | 1 | Q6UXS9 | |
| FLHCLKMMALEQGPD | 871 | A7MBM2 | |
| DPHIKEKALMAMNNL | 441 | Q7L311 | |
| MQPAQHGEIIKHMAK | 471 | O00203 | |
| IGMKMHVFNPIDSLE | 926 | O00203 | |
| MQRGKLDDIMEHPEK | 716 | Q6ZMN7 | |
| QRVMTKALDHGPDMK | 311 | A0A1B0GVH7 | |
| KALDHGPDMKAVINM | 316 | A0A1B0GVH7 | |
| DPALMIDGKEKNMHS | 436 | Q8N7Z5 | |
| HHEEMEMKNIEKPSG | 1156 | P43146 | |
| EPDSMLAHMFKDKGV | 111 | Q7L273 | |
| CRVNGIKMEMKGQPH | 1416 | P10071 | |
| IKMEMKGQPHPLCSN | 1421 | P10071 | |
| AVGAVMRKRKHMDEP | 56 | Q3KP22 | |
| MEDRLHMDNGLVPQK | 1 | P50747 | |
| GKKSVAHNMTMPNKL | 131 | P47869 | |
| LKQDIEHMKFPMGTQ | 1586 | P12107 | |
| EMFGPEGALKHMLKE | 291 | P49585 | |
| AEHKGKIIMHDPFAM | 486 | Q16822 | |
| IAKHMKHPQGDMIAE | 91 | O60437 | |
| MLSVPKKANDAMHVS | 1446 | O60229 | |
| PEGAFMKMLQARKQH | 756 | Q96QE4 | |
| GKKSVAHNMTMPNKL | 131 | P14867 | |
| EDHLMSAMNIKLGPA | 956 | Q8NDX5 | |
| MPGSEDLRKGKDQMH | 1 | A6NFQ7 | |
| KMEQRGLHAVMEALP | 416 | Q3B8N5 | |
| FLMEEVHMIKNKPAS | 471 | O15440 | |
| KMHIQSAVSKMNPGE | 1206 | Q8NFC6 | |
| LPNHAKNCVKMGLDM | 351 | Q08462 | |
| KKAQDALPFFMMHLG | 1036 | Q14008 | |
| AKGVSIPLMHEAMQK | 521 | Q6Y7W6 | |
| VDMLKNMLDKVHPER | 166 | A6NNT2 | |
| ISMPNAHGKIKAMIS | 696 | O75460 | |
| GHFELNVFKPMMIKN | 401 | P07954 | |
| EGKVPMHKLFLEMLE | 441 | P62508 | |
| SGPEALSAVKMEMKH | 1291 | Q8N3K9 | |
| SILPKHVADEMLKDM | 281 | O60266 | |
| IAMMSAKGHDGKEPV | 361 | Q6GMR7 | |
| KLMMEKLGAPQTHLG | 116 | Q9BUP0 | |
| ARHPSTKVMKQMDIG | 546 | Q6PJP8 | |
| KQSPHMQEGIKCMEG | 2061 | Q8NDH2 | |
| IMLKNDTKVLDAMPH | 111 | P52429 | |
| ELKLMMEKLGAPQTH | 116 | Q96C19 | |
| AAPTMIKMEVNGHGK | 1056 | Q9BXA9 | |
| LMLVDGIDPNFKMEH | 756 | Q9H9B1 | |
| GKVPMHKLFLEMLEA | 406 | P11474 | |
| HKPLNMGKVFEAMNS | 616 | P0C0L4 | |
| MHIKAMPEDAKGQVK | 131 | A8MW92 | |
| KDLKDRMAHAMNEYP | 171 | Q96GX9 | |
| KIKNMAHGSPKLVME | 111 | Q6ZUA9 | |
| EPQAAMFKVGMFKVH | 886 | Q99683 | |
| EPQAAMFKVGMFKIH | 856 | Q6ZN16 | |
| HLDLLDMKKMEKPQG | 121 | O95197 | |
| GEEMLHQPMEDNKKE | 1816 | P46939 | |
| LHPVKPMNAMATKVA | 1176 | Q6WKZ4 | |
| MDLENKVKKMGLGHE | 1 | Q9UGI8 | |
| HMVMIRGNSGLKPKD | 546 | Q9UKY4 | |
| CQKGILHKDSNMPMD | 1751 | P12259 | |
| ILKAGHMVPSDQGDM | 426 | Q9HB40 | |
| SMMGHEVKVPLLENF | 451 | A1A5C7 | |
| KMDKPMLKQAGSGVH | 531 | P57071 | |
| KDVMKASVMLEHDPQ | 1016 | O60841 | |
| MKEEMKEDVDPHNGA | 126 | Q9NV56 | |
| GMAHRMQKEIAALAP | 971 | P0CG39 | |
| GDHVEMAEQLGMKLP | 201 | Q8IXF0 | |
| LEHKPAKASMMQQPA | 211 | O00623 | |
| TGEKIPASKMQEHMR | 416 | Q15459 | |
| DIKPDNILMDMNGHI | 201 | Q5VT25 | |
| MFKDKDLTGPMNENH | 656 | Q14865 | |
| YAMSHNKGMDPEKLE | 506 | Q2KHT3 | |
| HDILDMMPEGIKQNK | 691 | Q6P2Q9 | |
| QGKEPCNMKRHAMVA | 91 | Q14593 | |
| EDHLMSAMNIKLGPA | 831 | Q8IXK0 | |
| EMDKMHAGLIDAIKP | 171 | O14656 | |
| LQTMHIMADLGPYKK | 201 | Q9NXB0 | |
| MGAFLDKPKMEKHNA | 1 | P35813 | |
| MERHVDPEALQKMAK | 51 | Q8NCR6 | |
| TPELGAVMHAMATKK | 81 | O75063 | |
| DSHSLKKDPVMPQNM | 646 | A0A0J9YWL9 | |
| KEEHLMSAMNIKLGP | 976 | P78364 | |
| EVRMDLKAKMPDDHA | 571 | Q96AE7 | |
| IDTMSPMHKNGDKEF | 606 | P11137 | |
| KMHAADLEKPMVEKQ | 386 | P54278 | |
| LEQGKKPLTMERHEM | 56 | O75346 | |
| KLKAADPTFVMGHAM | 56 | Q5R3I4 | |
| HPVNQMAKGTTEEMK | 796 | P33981 | |
| LEQGKKPSTMQRHEM | 56 | Q6ZN08 | |
| MHAADLEKPMVEKQD | 1 | Q68D20 | |
| MKLKMHADGDKSLPQ | 146 | Q8TCF1 | |
| ELLFHKMTDDPMNNK | 451 | P52735 | |
| VGFHMAKPDMIRKLE | 46 | Q96SR6 | |
| SHMSEGILMKKEPAE | 311 | O95405 | |
| PKRANDAMHLSMLEG | 1461 | O75962 | |
| HGEQNEVPGKKMKMH | 91 | Q5H9K5 | |
| EVPGKKMKMHVENFQ | 96 | Q5H9K5 | |
| LEQGKEPCNMKRHEM | 56 | Q9Y2Q1 | |
| MEEKAAPLLKEEMAH | 46 | Q96L15 | |
| SAPNHKLMAMEQGKT | 221 | Q7Z6G3 |